{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:53:06Z","timestamp":1784130786470,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2019YFC0118600"],"award-info":[{"award-number":["2019YFC0118600"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971011"],"award-info":[{"award-number":["81971011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["D171100008217005, 7202060"],"award-info":[{"award-number":["D171100008217005, 7202060"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Creutzfeldt-Jakob disease (CJD) is a fatal and irreversible neurodegenerative disease. Identification of inexpensive and easy-to-implement biomarkers of CJD which could predict disease severity and patient survival is important for improving disease management. The aim of this study was to assess the predictive value of peripheral neutrophil to lymphocyte ratio (NLR), high-density lipoprotein (HDL), monocyte to HDL ratio (MHR) and neutrophil to HDL ratio (NHR) for CJD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with definite or probable CJD admitted to the Neurology Department of Xuanwu Hospital from 2014 to 2021 were enrolled and followed up until April 2022. Clinical information including sex, age, Barth Index, survival time and results of auxiliary examination were collected, and NLR, HDL, NHR and MHR were measured for all enrolled patients. The associations between NLR, HDL, NHR and MHR, and disease severity (evaluated by Barth Index), survival time and auxiliary examinations were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 88 CJD patients were enrolled and all were deceased. NLR (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.341,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), NHR (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.346,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) and MHR (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.327,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) were significantly associated with disease severity. Higher NHR (HR\u2009=\u20092.344, 95% CI\u2009=\u20091.277\u20134.303\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) and lower HDL (HR\u2009=\u20090.567, 95% CI\u2009=\u20090.346\u20130.930,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025) were associated with shorter survival time in the CJD patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Peripheral inflammatory biomarkers, especially NHR, were associated with disease severity and survival duration. These findings provide new insights into the mechanisms and treatment strategies of CJD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-023-03076-y","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T02:02:54Z","timestamp":1674439374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neutrophil to High-density Lipoprotein ratio (NHR) as a potential predictor of disease severity and survival time in Creutzfeldt-Jakob disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Yu","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"issue":"Pt 5","key":"3076_CR1","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/brain\/awm063","volume":"130","author":"U Heinemann","year":"2007","unstructured":"Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(Pt 5):1350\u20139.","journal-title":"Brain"},{"issue":"Pt 10","key":"3076_CR2","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1093\/brain\/awh249","volume":"127","author":"M Pocchiari","year":"2004","unstructured":"Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Laupretre N, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004;127(Pt 10):2348\u201359.","journal-title":"Brain"},{"issue":"12","key":"3076_CR3","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nri3553","volume":"13","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi A, Nuvolone M, Zhu C. The immunobiology of prion diseases. Nat Rev Immunol. 2013;13(12):888\u2013902.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3076_CR4","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3390\/ijms22042196","volume":"22","author":"B Li","year":"2021","unstructured":"Li B, Chen M, Zhu C. Neuroinflammation in prion disease. Int J Mol Sci. 2021;22(4):2196.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3076_CR5","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/WNL.0b013e318265a55d","volume":"79","author":"F Fratini","year":"2012","unstructured":"Fratini F, Principe S, Puopolo M, Ladogana A, Poleggi A, Piscopo P, Bruno G, Castrechini S, Pascone R, Confaloni A, et al. Increased levels of acute-phase inflammatory proteins in plasma of patients with sporadic CJD. Neurology. 2012;79(10):1012\u20138.","journal-title":"Neurology"},{"issue":"12","key":"3076_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1046\/j.1537-2995.2001.41121509.x","volume":"41","author":"D V\u00f6lkel","year":"2001","unstructured":"V\u00f6lkel D, Zimmermann K, Zerr I, Lindner T, Bodemer M, Poser S, Schwarz HP. C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma? Transfusion. 2001;41(12):1509\u201314.","journal-title":"Transfusion"},{"issue":"1","key":"3076_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12974-019-1531-3","volume":"16","author":"A Villar-Piqu\u00e9","year":"2019","unstructured":"Villar-Piqu\u00e9 A, Schmitz M, Hermann P, Goebel S, Bunck T, Varges D, Ferrer I, Riggert J, Llorens F, Zerr I. Plasma YKL-40 in the spectrum of neurodegenerative dementia. J Neuroinflammation. 2019;16(1):145.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3076_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13195-022-00968-y","volume":"14","author":"JH Hou","year":"2022","unstructured":"Hou JH, Ou YN, Xu W, Zhang PF, Tan L, Yu JT. Association of peripheral immunity with cognition, neuroimaging, and Alzheimer\u2019s pathology. Alzheimers Res Ther. 2022;14(1):29.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"3076_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-021-00267-7","volume":"8","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cao B, Hou Y, Wei Q, Ou R, Zhao B, Shang H. High neutrophil-to-lymphocyte ratio predicts short survival in multiple system atrophy. NPJ Parkinsons Dis. 2022;8(1):11.","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"3076_CR10","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s10072-021-05507-5","volume":"43","author":"SP Kara","year":"2022","unstructured":"Kara SP, Altunan B, Unal A. Investigation of the peripheral inflammation (neutrophil-lymphocyte ratio) in two neurodegenerative diseases of the central nervous system. Neurol Sci. 2022;43(3):1799\u2013807.","journal-title":"Neurol Sci"},{"issue":"1","key":"3076_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/bbrc.2000.2372","volume":"270","author":"OF Olesen","year":"2000","unstructured":"Olesen OF, Dag\u00f8 L. High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Commun. 2000;270(1):62\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3076_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1161\/01.CIR.103.1.108","volume":"103","author":"GW Cockerill","year":"2001","unstructured":"Cockerill GW, Huehns TY, Weerasinghe A, Stocker C, Lerch PG, Miller NE, Haskard DO. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation. 2001;103(1):108\u201312.","journal-title":"Circulation"},{"issue":"8","key":"3076_CR13","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1161\/ATVBAHA.108.163998","volume":"28","author":"A Singh-Manoux","year":"2008","unstructured":"Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol. 2008;28(8):1556\u201362.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3076_CR14","first-page":"29","volume":"2","author":"MA Ward","year":"2010","unstructured":"Ward MA, Bendlin BB, McLaren DG, Hess TM, Gallagher CL, Kastman EK, Rowley HA, Asthana S, Carlsson CM, Sager MA, et al. Low HDL cholesterol is associated with lower gray matter volume in cognitively healthy adults. Front Aging Neurosci. 2010;2:29.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3076_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/09273948.2019.1611876","volume":"28","author":"Z Katipo\u011flu","year":"2020","unstructured":"Katipo\u011flu Z, Mirza E, Oltulu R, Katipoglu B. May Monocyte\/HDL Cholesterol Ratio (MHR) and Neutrophil\/Lymphocyte Ratio (NLR) be an indicator of inflammation and oxidative stress in patients with Keratoconus? Ocul Immunol Inflamm. 2020;28(4):632\u20136.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"3076_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12944-021-01462-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Fan Q, Wu S, Wan Y, Lei Y. Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson\u2019s disease. Lipids Health Dis. 2021;20(1):35.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"3076_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s12640-020-00274-1","volume":"38","author":"G Chen","year":"2020","unstructured":"Chen G, Yang N, Ren J, He Y, Huang H, Hu X, Shen J, Yang C, Zeng T, Hu J, et al. Neutrophil counts to high-density lipoprotein cholesterol ratio: a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis. Neurotox Res. 2020;38(4):1001\u20139.","journal-title":"Neurotox Res"},{"issue":"4","key":"3076_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/jcm7040076","volume":"7","author":"M Y\u0131lmaz","year":"2018","unstructured":"Y\u0131lmaz M, Kayan\u00e7i\u00e7ek H. A new inflammatory marker: elevated monocyte to HDL cholesterol ratio associated with smoking. J Clin Med. 2018;7(4):76.","journal-title":"J Clin Med"},{"issue":"Pt 10","key":"3076_CR19","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt 10):2659\u201368.","journal-title":"Brain"},{"key":"3076_CR20","unstructured":"CDC\u2019s Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD). Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP).\u00a02018. https:\/\/www.cdc.gov\/prions\/cjd\/diagnostic-criteria.html."},{"issue":"23","key":"3076_CR21","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/WNL.0b013e3182a9f3b4","volume":"81","author":"MD Geschwind","year":"2013","unstructured":"Geschwind MD, Kuo AL, Wong KS, Haman A, Devereux G, Raudabaugh BJ, Johnson DY, Torres-Chae CC, Finley R, Garcia P, et al. Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease. Neurology. 2013;81(23):2015\u201323.","journal-title":"Neurology"},{"issue":"2","key":"3076_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","volume":"13","author":"S Ha\u00efk","year":"2014","unstructured":"Ha\u00efk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, et al. Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13(2):150\u20138.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3076_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/jamaneurol.2015.3159","volume":"73","author":"L Eisenmenger","year":"2016","unstructured":"Eisenmenger L, Porter MC, Carswell CJ, Thompson A, Mead S, Rudge P, Collinge J, Brandner S, J\u00e4ger HR, Hyare H. Evolution of diffusion-weighted magnetic resonance imaging signal abnormality in sporadic Creutzfeldt-Jakob disease with histopathological correlation. JAMA Neurol. 2016;73(1):76\u201384.","journal-title":"JAMA Neurol"},{"issue":"3","key":"3076_CR24","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00330-021-08363-1","volume":"32","author":"HY Park","year":"2022","unstructured":"Park HY, Suh CH, Shim WH, Kim SO, Kim WS, Jeong S, Lee JH, Kim SJ. Prognostic value of diffusion-weighted imaging in patients with newly diagnosed sporadic Creutzfeldt-Jakob disease. Eur Radiol. 2022;32(3):1941\u201350.","journal-title":"Eur Radiol"},{"key":"3076_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.839081","volume":"13","author":"Y Kong","year":"2022","unstructured":"Kong Y, Chen Z, Zhang J, Wu L. Erythrocyte indices in Creutzfeldt-Jakob disease predict survival time. Front Neurol. 2022;13: 839081.","journal-title":"Front Neurol"},{"issue":"6","key":"3076_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4161\/19336896.2014.967040","volume":"8","author":"Q Shi","year":"2014","unstructured":"Shi Q, Shen XJ, Zhou W, Xiao K, Zhang XM, Zhang BY, Dong XP. Rare V180I mutation in PRNP gene of a Chinese patient with Creutzfeldt-Jakob disease. Prion. 2014;8(6):411\u20134.","journal-title":"Prion"},{"issue":"3","key":"3076_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058442","volume":"8","author":"W Zhao","year":"2013","unstructured":"Zhao W, Zhang JT, Xing XW, Huang DH, Tian CL, Jia WQ, Huang XS, Wu WP, Pu CQ, Lang SY, et al. Chinese specific characteristics of sporadic Creutzfeldt-Jakob disease: a retrospective analysis of 57 cases. PLoS ONE. 2013;8(3): e58442.","journal-title":"PLoS ONE"},{"issue":"4","key":"3076_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2188\/jea.JE20100085","volume":"21","author":"K Nagoshi","year":"2011","unstructured":"Nagoshi K, Sadakane A, Nakamura Y, Yamada M, Mizusawa H. Duration of prion disease is longer in Japan than in other countries. J Epidemiol. 2011;21(4):255\u201362.","journal-title":"J Epidemiol"},{"issue":"1","key":"3076_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000507189","volume":"83","author":"C Qi","year":"2020","unstructured":"Qi C, Zhang JT, Zhao W, Xing XW, Yu SY. Sporadic Creutzfeldt-Jakob disease: a retrospective analysis of 104 cases. Eur Neurol. 2020;83(1):65\u201372.","journal-title":"Eur Neurol"},{"issue":"11","key":"3076_CR30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/jnnp-2020-323231","volume":"91","author":"T Hamaguchi","year":"2020","unstructured":"Hamaguchi T, Sanjo N, Ae R, Nakamura Y, Sakai K, Takao M, Murayama S, Iwasaki Y, Satoh K, Murai H, et al. MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type. J Neurol Neurosurg Psychiatry. 2020;91(11):1158\u201365.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3076_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4103\/1673-5374.322476","volume":"17","author":"QQ Wei","year":"2022","unstructured":"Wei QQ, Hou YB, Zhang LY, Ou RW, Cao B, Chen YP, Shang HF. Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis. Neural Regen Res. 2022;17(4):875\u201380.","journal-title":"Neural Regen Res"},{"issue":"2","key":"3076_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10072-016-2758-8","volume":"38","author":"C Ata\u00e7 U\u00e7ar","year":"2017","unstructured":"Ata\u00e7 U\u00e7ar C, G\u00f6k\u00e7e \u00c7okal B, \u00dcnal Art\u0131k HA, \u0130nan LE, Yolda\u015f TK. Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson\u2019s disease subtypes. Neurol Sci. 2017;38(2):287\u201393.","journal-title":"Neurol Sci"},{"issue":"5","key":"3076_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/ane.13493","volume":"144","author":"D Sharma","year":"2021","unstructured":"Sharma D, Spring KJ, Bhaskar SMM. Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis. Acta Neurol Scand. 2021;144(5):486\u201399.","journal-title":"Acta Neurol Scand"},{"key":"3076_CR34","doi-asserted-by":"crossref","first-page":"117957352210925","DOI":"10.1177\/11795735221092518","volume":"14","author":"D Sharma","year":"2022","unstructured":"Sharma D, Spring KJ, Bhaskar SMM. Role of Neutrophil-lymphocyte ratio in the prognosis of acute ischaemic stroke after reperfusion therapy: a systematic review and meta-analysis. J Cent Nerv Syst Dis. 2022;14:11795735221092518.","journal-title":"J Cent Nerv Syst Dis"},{"key":"3076_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1742-2094-10-135","volume":"10","author":"K Fujita","year":"2013","unstructured":"Fujita K, Matsui N, Takahashi Y, Iwasaki Y, Yoshida M, Yuasa T, Izumi Y, Kaji R. Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia. J Neuroinflammation. 2013;10:135.","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"3076_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jneuroim.2005.10.008","volume":"172","author":"K Stoeck","year":"2006","unstructured":"Stoeck K, Bodemer M, Zerr I. Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol. 2006;172(1\u20132):175\u201381.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"3076_CR37","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1212\/WNL.52.6.1289","volume":"52","author":"MK Sharief","year":"1999","unstructured":"Sharief MK, Green A, Dick JP, Gawler J, Thompson EJ. Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease. Neurology. 1999;52(6):1289\u201391.","journal-title":"Neurology"},{"issue":"5","key":"3076_CR38","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.4049\/jimmunol.111.5.1407","volume":"111","author":"DD Porter","year":"1973","unstructured":"Porter DD, Porter HG, Cox NA. Failure to demonstrate a humoral immune response to scrapie infection in mice. J Immunol. 1973;111(5):1407\u201310.","journal-title":"J Immunol"},{"key":"3076_CR39","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3389\/fimmu.2018.02171","volume":"9","author":"E Mortaz","year":"2018","unstructured":"Mortaz E, Alipoor SD, Adcock IM, Mumby S, Koenderman L. Update on neutrophil function in severe inflammation. Front Immunol. 2018;9:2171.","journal-title":"Front Immunol"},{"issue":"6","key":"3076_CR40","first-page":"517","volume":"34","author":"G Miragliotta","year":"1990","unstructured":"Miragliotta G, Fumarulo R, Fumarola D. Inhibition of neutrophil functions by scrapie prion protein: description of some inhibitory properties. Acta Virol. 1990;34(6):517\u201322.","journal-title":"Acta Virol"},{"issue":"3","key":"3076_CR41","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1128\/iai.6.3.370-376.1972","volume":"6","author":"PC Licursi","year":"1972","unstructured":"Licursi PC, Merz PA, Merz GS, Carp RI. Scrapie-induced changes in the percentage of polymorphonuclear neutrophils in mouse peripheral blood. Infect Immun. 1972;6(3):370\u20136.","journal-title":"Infect Immun"},{"issue":"2","key":"3076_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1365-2567.1997.00331.x","volume":"92","author":"NA Mabbott","year":"1997","unstructured":"Mabbott NA, Brown KL, Manson J, Bruce ME. T-lymphocyte activation and the cellular form of the prion protein. Immunology. 1997;92(2):161\u20135.","journal-title":"Immunology"},{"issue":"3","key":"3076_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/cvr\/cvu148","volume":"103","author":"C Vitali","year":"2014","unstructured":"Vitali C, Wellington CL, Calabresi L. HDL and cholesterol handling in the brain. Cardiovasc Res. 2014;103(3):405\u201313.","journal-title":"Cardiovasc Res"},{"issue":"21","key":"3076_CR44","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1001\/jama.285.21.2729","volume":"285","author":"RL Sacco","year":"2001","unstructured":"Sacco RL, Benson RT, Kargman DE, Boden-Albala B, Tuck C, Lin IF, Cheng JF, Paik MC, Shea S, Berglund L. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan stroke study. JAMA. 2001;285(21):2729\u201335.","journal-title":"JAMA"},{"issue":"15","key":"3076_CR45","doi-asserted-by":"publisher","first-page":"14983","DOI":"10.1074\/jbc.M313061200","volume":"279","author":"C Bate","year":"2004","unstructured":"Bate C, Salmona M, Diomede L, Williams A. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J Biol Chem. 2004;279(15):14983\u201390.","journal-title":"J Biol Chem"},{"issue":"11","key":"3076_CR46","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1128\/AAC.00524-07","volume":"51","author":"A Pani","year":"2007","unstructured":"Pani A, Norfo C, Abete C, Mulas C, Putzolu M, Laconi S, Orr\u00f9 CD, Cannas MD, Vascellari S, La Colla P, et al. Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines. Antimicrob Agents Chemother. 2007;51(11):4141\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3076_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X","volume":"48","author":"AM Fagan","year":"2000","unstructured":"Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM. Differences in the Abeta40\/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol. 2000;48(2):201\u201310.","journal-title":"Ann Neurol"},{"issue":"10","key":"3076_CR48","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1194\/jlr.M073718","volume":"58","author":"V Perrier","year":"2017","unstructured":"Perrier V, Imberdis T, Lafon PA, Cefis M, Wang Y, Huetter E, Arnaud JD, Alvarez-Martinez T, Le Guern N, Maquart G, et al. Plasma cholesterol level determines in vivo prion propagation. J Lipid Res. 2017;58(10):1950\u201361.","journal-title":"J Lipid Res"},{"issue":"6","key":"3076_CR49","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","volume":"31","author":"AJ Murphy","year":"2011","unstructured":"Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, Sviridov D, Chin-Dusting JP. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol. 2011;31(6):1333\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"3076_CR50","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1046\/j.1432-1327.2001.02253.x","volume":"268","author":"C Bergt","year":"2001","unstructured":"Bergt C, Marsche G, Panzenboeck U, Heinecke JW, Malle E, Sattler W. Human neutrophils employ the myeloperoxidase\/hydrogen peroxide\/chloride system to oxidatively damage apolipoprotein A-I. Eur J Biochem. 2001;268(12):3523\u201331.","journal-title":"Eur J Biochem"},{"issue":"5","key":"3076_CR51","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.clinph.2005.12.007","volume":"117","author":"HG Wieser","year":"2006","unstructured":"Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol. 2006;117(5):935\u201351.","journal-title":"Clin Neurophysiol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03076-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T03:05:09Z","timestamp":1674443109000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03076-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3076"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03076-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2099531\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"24 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Xuanwu Hospital, Capital Medical University approved the study. All participants and\/or their legal guardians signed the written informed consent. All methods were carried out in Accordance with relevant guidelines and Regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}